Georgina Nock

Georgina Nock becomes Chair for the Late Phase Working Group of EUCROF.

We are proud to announce that Georgina Nock, Associate Director at pH Associates (an OPEN Health company), has been appointed as Chair for the Late Phase Working Group of EUCROF.   The objective of EUCROF (the European CRO Federation), a non-profit organization founded in 2005, is to promote Clinical Research by improving the knowledge, competence/expertise and…

Evidence in Digital Therapeutics – Proof and Power

The key differentiator between ‘digital health and wellbeing technologies’ and ‘digital therapeutics’ is that the latter must show improved outcomes. Approximately 140 studies were published in 2017 which contained clinical evidence of digital health efficacy [1]. Clinically validated technologies have looked to show value for health systems by reducing emergency hospitalisation, A&E, ambulatory, drug and…

Highlights from NICE 2018 – Tackling Antimicrobial Resistance Globally and Locally

pH Associates were delighted to meet with current and former clients at the NICE Conference #NICEConf18 last week and to have the opportunity to attend some thought-provoking breakout sessions.  Of particular interest was a topical session focused on ‘Tackling Antimicrobial Resistance Globally and Locally’, with Nick Crabb (Programme Director, Scientific Affairs, NICE), Susan Hopkins (Chair…